Skip to main content
OpenTrials

Clinical trial condition

Soft Tissue Sarcoma

Explore clinical trials studying Soft Tissue Sarcoma. Study availability and eligibility vary by location and protocol.

197 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Soft Tissue Sarcoma trial results

Completed

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

NCT03365791

Conditions
Adenocarcinoma Of Esophagus, Advanced Well-differentiated Neuroendocrine Tumors, Bronchial Neoplasms, +28 more
Locations
  • California Pacific Medical Center Drug Shipment (2) San Francisco, California, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • University Cancer and Blood Center, LLC Athens, Georgia, United States
  • Northwestern University Medical School Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma

NCT02659020

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations
  • UCLA Medical Center Santa Monica, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Mayo Clinic-Jacksonville Jacksonville, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 48 locations
View Trial Details
Completed

A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas

NCT01140737

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom
  • Western General Hospital Edinburgh, Scotland, United Kingdom
  • Bristol Haematology & Oncology Centre Bristol, United Kingdom
  • St. James's Hospital Leeds, United Kingdom
View all 13 locations
View Trial Details
Completed

Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

NCT02192333

Conditions
Behavior, Behavioral Symptoms, Bone Diseases, +40 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
View Trial Details
Completed

SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas

NCT02301039

Conditions
Bone Diseases, Bone Neoplasms, Bone Sarcoma, +7 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Medstar Health Research Institute Washington D.C., District of Columbia, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

NCT03283696

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations
  • University of Miami School of Medicine Miami, Florida, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Universitätsklinikum Essen Essen, North Rhine-Westphalia, Germany
  • HELIOS Klinikum Berlin-Buch Berlin, Germany
View Trial Details

Related conditions